BLR’s therapy regulates the overproduction of key pro-disease proteins
In fibrotic disease and solid tumor cancer the interaction of cells, proteins and extracellular matrix drives disease. Overabundant pro-disease proteins bind to receptors on cells and the extracellular matrix. CCN protein imbalances are key drivers of disease creating excessive binding with receptors. Regulating overproduction of key proteins reduces pro-disease signaling and allows body to return to homeostasis